Sheng Tong, Pasquesi Lauren, Gilligan Jennifer, Chen Xing-Jie, Swaminathan Jayaganesh
Eargo, Inc., San Jose, CA, United States.
Front Neurosci. 2024 Apr 18;18:1373729. doi: 10.3389/fnins.2024.1373729. eCollection 2024.
In 2022, the US Food and Drug Administration enacted final regulations to establish the category of over-the-counter (OTC) hearing aids aimed at reducing barriers to access hearing health care for individuals with self-perceived mild to moderate hearing loss. However, given the infancy of this device category, the effectiveness of OTC hearing aids in real-world environments is not yet well understood.
To gain insights into the perceived benefit of self-fitting OTC hearing aids, a two-pronged investigation was conducted. In the primary investigation, 255 active users of a self-fitting OTC hearing aid were surveyed on their perceived benefit using an abridged form of the Satisfaction with Amplification in Daily Living (SADL) scale. The mean global (4.9) and subscale scores (Positive Effect (PE): 4.3; Negative Features (NF): 4.3; Personal Image (PI): 6.1) were within the range of those previously reported for users of prescription hearing aids. In the secondary investigation, 29 individuals with self-reported hearing impairment but no prior experience with the investigational self-fitting OTC hearing aids used the devices and reported their perceived benefit and satisfaction following short-term usage. For this prospective group, the global SADL (5.4) and subscale scores (PE: 4.8; NF: 4.9; PI: 6.5) following a minimum of 10 weeks of real-world use were also within the range of those previously reported for traditional hearing aid users. In addition, this prospective group was also asked quality of life questions which assessed psychological benefits of hearing aid use. Responses to these items suggest hearing aid related improvements in several areas spanning emotional health, relationships at home and at work, social life, participation in group activities, confidence and feelings about one's self, ability to communicate effectively, and romance.
Converging data from these investigations suggest that self-fitting OTC hearing aids can potentially provide their intended users with a level of subjective benefit comparable to what prescription hearing aid users might experience.
2022年,美国食品药品监督管理局颁布了最终法规,设立了非处方(OTC)助听器类别,旨在减少自我感觉有轻度至中度听力损失的个人获得听力保健服务的障碍。然而,鉴于这一设备类别的发展尚不成熟,非处方助听器在现实环境中的有效性尚未得到充分了解。
为了深入了解自我适配非处方助听器的感知益处,进行了一项双管齐下的调查。在主要调查中,对255名自我适配非处方助听器的活跃用户使用简化版的日常生活放大满意度(SADL)量表进行了感知益处调查。总体平均得分(4.9)和子量表得分(积极影响(PE):4.3;负面特征(NF):4.3;个人形象(PI):6.1)在先前报道的处方助听器用户得分范围内。在次要调查中,29名自我报告有听力障碍但此前没有使用过该试验性自我适配非处方助听器经验的个体使用了这些设备,并在短期使用后报告了他们的感知益处和满意度。对于这个前瞻性群体,在至少10周的实际使用后的总体SADL得分(5.4)和子量表得分(PE:4.8;NF:4.9;PI:6.5)也在先前报道的传统助听器用户得分范围内。此外,还向这个前瞻性群体询问了生活质量问题,这些问题评估了使用助听器的心理益处。对这些问题的回答表明,在情感健康、家庭和工作关系、社交生活、参与团体活动、自信和自我感觉、有效沟通能力以及浪漫关系等几个方面,与助听器相关的情况有所改善。
这些调查得出的数据表明,自我适配非处方助听器有可能为其目标用户提供与处方助听器用户可能体验到的相当的主观益处。